← Back to Clinical Trials
Recruiting NCT06982261

NCT06982261 Voice Technology-Based Self-Management Intervention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06982261
Status Recruiting
Phase —
Sponsor Emory University
Condition Mild Cognitive Impairment
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-07-15
Primary Completion 2026-10

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Voice-activated smart speakers

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-07-15 with a primary completion date of 2026-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to test a new technology-based program designed to help improve the ability to manage chronic conditions. This program includes daily smart speaker use for managing different tasks and technology learning. Proper self-management of chronic conditions is critical to the maintenance of health. Digital technologies offer substantial potential to enhance self-management behaviors. Voice-operated smart speakers hold promise due to their ability to provide functional, cognitive, and social stimulation, send targeted reminders, and assist with daily schedules. Unfortunately, many older adults who live in low-income communities lack the resources and proficiency to take advantage of these options. Additionally, cognitive impairment is prevalent in independent living older adults, more prevalent in low-income older adults. The goal is to address these critical challenges by identifying smart speaker-based functions preferred by older adults, exploring their technology challenges, introducing them to these functions, and providing necessary technology training to improve self-efficacy in managing chronic conditions and enhance their engagement in self-management behaviors.

Eligibility Criteria

Inclusion Criteria: * Persons 55 years of age and older, * Living in subsidized housing or with a housing voucher and having an annual income less than $30K, * One or more chronic conditions, * Having probable mild cognitive impairment (MCI), based on the education-adjusted Montreal Cognitive Assessment (MoCA) score less than 24 and greater than or equal to 18, * Living alone independently, and * Able to speak and read English. Exclusion Criteria: * Severe visual/hearing impairment requiring assistance in participating in interactions with the smart speaker and integrated devices, * Self-reported diagnoses of Alzheimer's disease and related dementias, * Significant medical illness interfering with the study assessments and activities, * Inability to provide informed consent, and * Nursing home residents. * Eligibility will not be limited to smart speaker ownership.

Contact & Investigator

Central Contact

Jane Chung, PhD, RN

✉ Jane.chung@emory.edu

📞 404-544-9589

Principal Investigator

Jane Chung, PhD, RN

PRINCIPAL INVESTIGATOR

Emory University - Nell Hodgson Woodruff School of Nursing

Frequently Asked Questions

Who can join the NCT06982261 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, studying Mild Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06982261 currently recruiting?

Yes, NCT06982261 is actively recruiting participants. Contact the research team at Jane.chung@emory.edu for enrollment information.

Where is the NCT06982261 trial being conducted?

This trial is being conducted at Atlanta, United States.

Who is sponsoring the NCT06982261 clinical trial?

NCT06982261 is sponsored by Emory University. The principal investigator is Jane Chung, PhD, RN at Emory University - Nell Hodgson Woodruff School of Nursing. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology